Global Targeted Alpha-Therapy Market Report 2025

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Targeted Alpha-Therapy Global Market Report 2025

Name: Targeted Alpha-Therapy Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Isotope Type (Actinium-225, Radium-223, Lead-212, Bismuth-213, Other Isotype Types); By Application (Prostate Cancer, Bone Metastases, Pancreatic Cancer, Other Applications); By End-User (Hospitals, Cancer Research Institutes, Specialty Clinics, Lymphoma, Other End Users); Subsegments:; By Actinium-225 (Ac-225 Lintuzumab, Ac-225 PSMA-617, Ac-225 DOTATATE); By Radium-223 (Radium-223 Dichloride (Xofigo)); By Lead-212 (Pb-212 DOTAMTATE (AlphaMedix), Pb-212 TCMC-Trastuzumab); By Bismuth-213 (Bi-213 Lintuzumab, Bi-213 DOTATOC); By Other Isotope Types (Thorium-227, Astatine-211, Terbium-149) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Targeted Alpha-Therapy Market Overview

• Targeted Alpha-Therapy market size has reached to $0.87 billion in 2024

• Expected to grow to $1.93 billion in 2029 at a compound annual growth rate (CAGR) of 17.1%

• Growth Driver: Rising Adoption Of Precision Medicine Driving The Market Growth Due To Increasing Genetic Testing And Personalized Treatment Approaches

• Market Trend: Advancements In Precision Alpha-Emitter Cancer Treatments

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Targeted Alpha-Therapy Market?

Targeted alpha-therapy (TAT) refers to a form of radiation therapy that delivers highly potent alpha-particle-emitting isotopes directly to cancer cells or diseased tissues. The therapy uses targeting molecules, such as antibodies, peptides, or small molecules, that bind specifically to cancer cell markers, allowing the alpha particles to cause lethal double-strand DNA breaks in nearby cells while minimizing damage to surrounding healthy tissue.

The main isotope types of targeted alpha therapy are actinium-225, radium-223, lead-212, bismuth-213, and others. Actinium-225 refers to a potent alpha-emitting radioisotope widely used in targeted therapies due to its favorable half-life and decay properties. This therapy is applied in conditions including Prostate Cancer, bone metastases, pancreatic cancer, and others, serving end-users including hospitals, cancer research institutes, specialty clinics, lymphoma, and others.

Targeted Alpha-Therapy Market Size and growth rate 2025 to 2029: Graph

What Is The Targeted Alpha-Therapy Market Size 2025 And Growth Rate?

What Is The Targeted Alpha-Therapy Market Growth Forecast?

The targeted alpha-therapy market size is expected to see rapid growth in the next few years. It will grow to $1.93 billion in 2029 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to increasing prevalence of cancer and metastatic diseases, rising adoption of precision medicine, growing awareness among oncologists and patients, increasing research and development investments, and rising number of clinical trials. Major trends in the forecast period include advancements in radiopharmaceutical technology, technological developments in alpha-emitter production, integration of imaging and therapy, advancements in targeted drug delivery systems, and developments in nuclear medicine technologies.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How the Targeted Alpha-Therapy Market Segmented?

1) By Isotope Type: Actinium-225, Radium-223, Lead-212, Bismuth-213, Other Isotype Types

2) By Application: Prostate Cancer, Bone Metastases, Pancreatic Cancer, Other Applications

3) By End-User: Hospitals, Cancer Research Institutes, Specialty Clinics, Lymphoma, Other End Users

Subsegments:

1) By Actinium-225: Ac-225 Lintuzumab, Ac-225 PSMA-617, Ac-225 DOTATATE

2) By Radium-223: Radium-223 Dichloride (Xofigo)

3) By Lead-212: Pb-212 DOTAMTATE (AlphaMedix), Pb-212 TCMC-Trastuzumab

4) By Bismuth-213: Bi-213 Lintuzumab, Bi-213 DOTATOC

5) By Other Isotope Types: Thorium-227, Astatine-211, Terbium-149

What Is Driving The Targeted Alpha-Therapy Market? Rising Adoption Of Precision Medicine Driving The Market Growth Due To Increasing Genetic Testing And Personalized Treatment Approaches

The growing focus on precision medicine is expected to propel the growth of the targeted alpha-therapy market going forward. Precision medicine refers to a healthcare approach that customizes prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment for more effective outcomes. Precision medicine is increasing because the growing availability of genetic testing enables more accurate diagnoses and targeted treatments with improved patient outcomes. Targeted alpha-therapy helps in precision medicine by delivering highly potent alpha-emitting isotopes directly to cancer cells, enabling personalized and precise treatment while minimizing damage to healthy tissues. For instance, in March 2024, according to the American Pharmaceutical Review, a US-based journal company, global spending on precision medicine treatments was nearly $32 billion in 2022 and is projected to exceed $124 billion by 2027. Therefore, the growing focus on precision medicine is driving the growth of the targeted alpha-therapy industry.

Who Are The Major Players In The Global Targeted Alpha-Therapy Market?

Major companies operating in the targeted alpha-therapy market are Bayer Aktiengesellschaft, Novartis AG, Lantheus Holdings Inc., Telix Pharmaceuticals Limited, Eckert & Ziegler Strahlen- und Medizintechnik AG, Actinium Pharmaceuticals Inc., RayzeBio Inc., ITM Isotope Technologies Munich SE, ARTBIO Inc., AdvanCell Pty Ltd., IONETIX Corporation, Abdera Therapeutics Inc., Aktis Oncology Inc., Alpha-9 Oncology Inc., Clarity Pharmaceuticals Pty Ltd., Nucleus RadioPharma, Oncoinvent AS, PanTera, Perspective Therapeutics Inc., RadioMedix Inc.

What Are The Key Trends Of The Global Targeted Alpha-Therapy Market? Advancements In Precision Alpha-Emitter Cancer Treatments

Major companies operating in the targeted alpha-therapy market are focusing on developing innovative solutions such as peptide receptor radionuclide therapy to improve targeted cancer treatment efficacy, minimize off-target effects, and enhance patient outcomes. Peptide receptor radionuclide therapy (PRRT) refers to a targeted cancer treatment that delivers radioactive isotopes directly to tumor cells by binding them to peptides that specifically attach to receptors overexpressed on cancer cells, thereby minimizing damage to healthy tissue. For instance, in February 2024, RadioMedix Inc., a US-based biotechnology company, partnered with Orano Med, a US-based pharma company, and received the first targeted alpha therapy to win FDA breakthrough device designation is AlphaMedix (lead-212-Dotamtate), aimed at treating neuroendocrine tumors. It is designed to treat advanced gastroenteropancreatic neuroendocrine tumors by delivering highly potent alpha radiation directly to cancer cells while sparing healthy tissue. Its key advantage lies in the high energy and short path length of alpha particles, which cause lethal DNA damage to tumor cells with minimal toxicity. This therapy offers a promising option for patients who are naïve to or have limited response to current beta-emitter treatments, aiming to improve efficacy and safety in difficult-to-treat neuroendocrine tumors.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Targeted Alpha-Therapy Market? Lohmann & Rauscher Acquires Teledermatology Startup Onlinedoctor To Expand Digital Healthcare Solutions

In June 2024, AstraZeneca Plc, a UK-based pharmaceutical industry company, acquired Fusion Pharmaceuticals Inc. for an undisclosed amount. With this acquisition AstraZeneca aims to transform cancer treatment and patient outcomes by developing more precise, targeted next-generation radioconjugate therapies that replace traditional chemotherapy and radiotherapy. Fusion Pharmaceuticals Inc. is a Canada-based biotech company that offers targeted alpha-therapy.

What Is The Regional Outlook For The Global Targeted Alpha-Therapy Market?

North America was the largest region in the targeted alpha-therapy market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Targeted Alpha-Therapy Market?

The targeted alpha-therapy market consists of sales of neptunium-225 thorium-227 and astatine-211. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Targeted Alpha-Therapy Industry?

The targeted alpha-therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the targeted alpha-therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

1. Executive Summary

2. Targeted Alpha-Therapy Market Characteristics

3. Targeted Alpha-Therapy Market Trends And Strategies

4. Targeted Alpha-Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Targeted Alpha-Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Targeted Alpha-Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Targeted Alpha-Therapy Market Growth Rate Analysis

5.4. Global Targeted Alpha-Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Targeted Alpha-Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Targeted Alpha-Therapy Total Addressable Market (TAM)

6. Targeted Alpha-Therapy Market Segmentation

6.1. Global Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Actinium-225

Radium-223

Lead-212

Bismuth-213

Other Isotype Types

6.2. Global Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prostate Cancer

Bone Metastases

Pancreatic Cancer

Lymphoma

Other Applications

6.3. Global Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Cancer Research Institutes

Specialty Clinics

Other End Users

6.4. Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Actinium-225, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ac-225 Lintuzumab

Ac-225 PSMA-617

Ac-225 DOTATATE

6.5. Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Radium-223, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Radium-223 Dichloride (Xofigo)

6.6. Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Lead-212, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pb-212 DOTAMTATE (AlphaMedix)

Pb-212 TCMC-Trastuzumab

6.7. Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Bismuth-213, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bi-213 Lintuzumab

Bi-213 DOTATOC

6.8. Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Other Isotope Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Thorium-227

Astatine-211

Terbium-149

7. Targeted Alpha-Therapy Market Regional And Country Analysis

7.1. Global Targeted Alpha-Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Targeted Alpha-Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Targeted Alpha-Therapy Market

8.1. Asia-Pacific Targeted Alpha-Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Targeted Alpha-Therapy Market

9.1. China Targeted Alpha-Therapy Market Overview

9.2. China Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Targeted Alpha-Therapy Market

10.1. India Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Targeted Alpha-Therapy Market

11.1. Japan Targeted Alpha-Therapy Market Overview

11.2. Japan Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Targeted Alpha-Therapy Market

12.1. Australia Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Targeted Alpha-Therapy Market

13.1. Indonesia Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Targeted Alpha-Therapy Market

14.1. South Korea Targeted Alpha-Therapy Market Overview

14.2. South Korea Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Targeted Alpha-Therapy Market

15.1. Western Europe Targeted Alpha-Therapy Market Overview

15.2. Western Europe Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Targeted Alpha-Therapy Market

16.1. UK Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Targeted Alpha-Therapy Market

17.1. Germany Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Targeted Alpha-Therapy Market

18.1. France Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Targeted Alpha-Therapy Market

19.1. Italy Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Targeted Alpha-Therapy Market

20.1. Spain Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Targeted Alpha-Therapy Market

21.1. Eastern Europe Targeted Alpha-Therapy Market Overview

21.2. Eastern Europe Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Targeted Alpha-Therapy Market

22.1. Russia Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Targeted Alpha-Therapy Market

23.1. North America Targeted Alpha-Therapy Market Overview

23.2. North America Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Targeted Alpha-Therapy Market

24.1. USA Targeted Alpha-Therapy Market Overview

24.2. USA Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Targeted Alpha-Therapy Market

25.1. Canada Targeted Alpha-Therapy Market Overview

25.2. Canada Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Targeted Alpha-Therapy Market

26.1. South America Targeted Alpha-Therapy Market Overview

26.2. South America Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Targeted Alpha-Therapy Market

27.1. Brazil Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Targeted Alpha-Therapy Market

28.1. Middle East Targeted Alpha-Therapy Market Overview

28.2. Middle East Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Targeted Alpha-Therapy Market

29.1. Africa Targeted Alpha-Therapy Market Overview

29.2. Africa Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Targeted Alpha-Therapy Market Competitive Landscape And Company Profiles

30.1. Targeted Alpha-Therapy Market Competitive Landscape

30.2. Targeted Alpha-Therapy Market Company Profiles

30.2.1. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Telix Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eckert & Ziegler Strahlen- und Medizintechnik AG Overview, Products and Services, Strategy and Financial Analysis

31. Targeted Alpha-Therapy Market Other Major And Innovative Companies

31.1. Actinium Pharmaceuticals Inc.

31.2. RayzeBio Inc.

31.3. ITM Isotope Technologies Munich SE

31.4. ARTBIO Inc.

31.5. AdvanCell Pty Ltd.

31.6. IONETIX Corporation

31.7. Abdera Therapeutics Inc.

31.8. Aktis Oncology Inc.

31.9. Alpha-9 Oncology Inc.

31.10. Clarity Pharmaceuticals Pty Ltd.

31.11. Nucleus RadioPharma

31.12. Oncoinvent AS

31.13. PanTera

31.14. Perspective Therapeutics Inc.

31.15. RadioMedix Inc.

32. Global Targeted Alpha-Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Targeted Alpha-Therapy Market

34. Recent Developments In The Targeted Alpha-Therapy Market

35. Targeted Alpha-Therapy Market High Potential Countries, Segments and Strategies

35.1 Targeted Alpha-Therapy Market In 2029 - Countries Offering Most New Opportunities

35.2 Targeted Alpha-Therapy Market In 2029 - Segments Offering Most New Opportunities

35.3 Targeted Alpha-Therapy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Actinium-225, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Radium-223, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Lead-212, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Bismuth-213, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Other Isotope Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Targeted Alpha-Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Targeted Alpha-Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Bayer Aktiengesellschaft Financial Performance

Table 80: Novartis AG Financial Performance

Table 81: Lantheus Holdings Inc. Financial Performance

Table 82: Telix Pharmaceuticals Limited Financial Performance

Table 83: Eckert & Ziegler Strahlen- und Medizintechnik AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Actinium-225, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Radium-223, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Lead-212, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Bismuth-213, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Other Isotope Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Targeted Alpha-Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Targeted Alpha-Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Bayer Aktiengesellschaft Financial Performance

Figure 80: Novartis AG Financial Performance

Figure 81: Lantheus Holdings Inc. Financial Performance

Figure 82: Telix Pharmaceuticals Limited Financial Performance

Figure 83: Eckert & Ziegler Strahlen- und Medizintechnik AG Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Alpha Hydroxy Acid Global Market Report 2025 – By Product (Glycolic Acid, Lactic Acid, Citric Acid, Other Products), By Source (Natural, Synthetic), By Application (Cosmetics, Dermal) – Impact of Tariff and Trade War on ...

Alpha-1 Antitrypsin Deficiency Augmentation Therapy Global Market Report 2025 – By Product Type (Glassia, Aralast NP, Prolastin C, Zemaira And Respreeza), By Route Of Administration (Oral, Injection, Inhalation), By End ...

Drugs For Hormonal Replacement Therapy Global Market Report 2025 – By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Ther...

Alpha Methyldopa Global Market Report 2025 – By Type (Oral, Intravenous Drip), By Purity Type (Purity (=98%), Purity (=99%)), By Application (Parkinsonism, Hepatic Coma) – Market Size, Trends, And Global Forecast 2025-20...

Hormone Therapy Global Market Report 2025 – By Therapy (Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement), By Route of Administration (Oral, Parenteral, Othe...

mRNA Therapeutics Global Market Report 2025 – By Product (Vaccines, Drugs), By Application (Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications), By End Use (Hospitals And Clini...

Testosterone Replacement Therapy Global Market Report 2025 – By Product Type (Oral, Implants, Gel Or Creams, Patches, Buccal Adhesive, Parenteral, Other Products), By Indication (Hypogonadism, Autoimmune Conditions, Gene...

Frequently Asked Questions

What is the definition of the Targeted Alpha-Therapy market?

How will the Targeted Alpha-Therapy market drivers and restraints affect the market dynamics? What forces will shape the Targeted Alpha-Therapy industry going forward?

The market major growth driver - Rising Adoption Of Precision Medicine Driving The Market Growth Due To Increasing Genetic Testing And Personalized Treatment Approaches. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Targeted Alpha-Therapy market?

The targeted alpha-therapy market size has grown rapidly in recent years. It will grow from $0.87 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to increasing regulatory approvals, growing focus on targeted therapy over conventional chemotherapy, increasing availability of alpha-emitting isotopes, rising government and private funding, and increasing patient preference for minimally invasive therapies. The targeted alpha-therapy market size is expected to see rapid growth in the next few years. It will grow to $1.93 billion in 2029 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to increasing prevalence of cancer and metastatic diseases, rising adoption of precision medicine, growing awareness among oncologists and patients, increasing research and development investments, and rising number of clinical trials. Major trends in the forecast period include advancements in radiopharmaceutical technology, technological developments in alpha-emitter production, integration of imaging and therapy, advancements in targeted drug delivery systems, and developments in nuclear medicine technologies. For further insights on this market, request a sample here

How is the Targeted Alpha-Therapy market segmented?

The targeted alpha-therapy market covered in this report is segmented as
1) By Isotope Type: Actinium-225, Radium-223, Lead-212, Bismuth-213, Other Isotype Types
2) By Application: Prostate Cancer, Bone Metastases, Pancreatic Cancer, Other Applications
3) By End-User: Hospitals, Cancer Research Institutes, Specialty Clinics, Lymphoma, Other End Users Subsegments:
1) By Actinium-225: Ac-225 Lintuzumab, Ac-225 PSMA-617, Ac-225 DOTATATE
2) By Radium-223: Radium-223 Dichloride (Xofigo)
3) By Lead-212: Pb-212 DOTAMTATE (AlphaMedix), Pb-212 TCMC-Trastuzumab
4) By Bismuth-213: Bi-213 Lintuzumab, Bi-213 DOTATOC
5) By Other Isotope Types: Thorium-227, Astatine-211, Terbium-149 For further insights on this market, request a sample here

Which region has the largest share of the Targeted Alpha-Therapy market? What are the other regions covered in the report?

North America was the largest region in the targeted alpha-therapy market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in targeted alpha-therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Who are the major players in the Targeted Alpha-Therapy market?

What are the key trends in the Targeted Alpha-Therapy market?

Major trends in this market include Advancements In Precision Alpha-Emitter Cancer Treatments For further insights on this market, request a sample here.